======= ======= ====== ====== ====== ===== ==== ====== ====== ===== ==== ======= ======= ====== ====== ====== ===== ==== ====== ====== ===== ====
In partnership with Raging Bull
I’m gun shy, guys. I’m peering through the scope and gently breathing out as my finger hovers atop the track pad, but I haven’t pulled trig yet. I know one trade isn’t likely to make or break me. Frankly, it’s more about getting comfortable using E*TRADE and learning how to watch the ebbs and flows of a stock after I make a move. But being somewhat of a perfectionist is a detriment in this game.
Last Wednesday, I touched base with my mentor, Kyle, who we introduced in our Day Traders launch a week ago. Kyle’s specialty is Biotech, which is street slang for Biotechnology if you’re new here. One of the benefits of using a boot camp program like Raging Bull is the live updates sent to your inbox whenever your mentor sees something noteworthy or makes a move. Admittedly, it can be overwhelming at first. There’s a lot of information out there, and my number one goal with this partnership, aside from putting Will in a bodybag, is to become more knowledgable of the market. During my time as a starting cornerback on my 8th grade B team, I lived in the film room. You couldn’t drag me out of there. I still believe in the power of preparation. I’m applying it to this little competition as much as I can. That’s why I love getting email blasts like this:
Good afternoon,
Going further on the “biotech penny stock” theme, CLDX popped up on my radar.
If you go to check out their catalyst, the company is set to report data in the second half of 2018.
In fact, in this press release they say that they plan to “present data from the glioblastoma cohort at a medical meeting later this year.”
What I find interesting is that the company has yet to release a press release (PR) that I can find that they will be at the upcoming ESMO conference. They are on the official ESMO docket which you can see right here.
Therefore, given that this catalyst should be in a few days and the company has yet to PR anything about it that I can find — I think this is under appreciated by the market.
I bought 40k CLDX at .42 and will be initially looking for 30% gain, although more is possible if the market agrees with me.
For the record, we don’t have any affiliation with Celldex Therapeutics, Inc. I’m merely using this email to demonstrate what we’re doing here. It’s rudimentary stuff for the well informed, but day traders are looking for “catalyst events” that will cause the price of a stock or security to move up or down. It can be company news, earnings releases, or in the case of a Biotech stock, an FDA approval. It’s like finding out whether or not your boss is picking up the tab at happy hour. It really changes everything. Here’s a writeup courtesy of Kyle that I found very helpful.
Despite the fact that I haven’t made a move yet, I can see how this could become addicting. Doing your homework and utilizing the E*TRADE research tools is oddly fun for me right now. It’s a different style of busy work that, believe it or not, I don’t see on a day-to-day basis here at Grandex. With that being said, the people who are successful in this business are devoting a lot of time and effort into the process. It’s definitely not something that you can dabble in as a hobby and expect to hit it big. We’ll see how that plays out for a lawyer-podcast guy..
Things Guys Do After Graduation: Pump and dump biotech penny stocks in a blog
legit just bought at 0.4520
Lol, good luck. This is why there are generally pages of disclosures attached to any sell-side research report on a stock, written by a massive compliance department to save their ass from a lawsuit.
I like to play along, okay buzz-killington?
Is it normal for a company to have a investment calculator on their website? I have never seen this before……
Followed by: Pay Hefty SEC Fines for Insider Trading and Market Manipulation
guys, it’s all about pairs trading where you maximize gains from both ends of a certain spectrum. Sometimes the 2 endpoints in the pair aren’t directly correlated but they make sense in a longer term view.
For example, investing in weapons manufacturers, defense contractors, lithium ion mine streaming companies, oil, and water and then investing in private prison companies, Amazon (Rekognition), and your neighborhood drug dealer. oh, and sober treatment clinics and hospitals.
Remember guys, manufactured hate and fiat money make the rich world go round lol
Hammer 3x Leveraged ETFs with minimal research. Stop Losses and Limit Sells.
Buy options, depending on your time frame preferably out of the money, on stocks that have a relatively high beta. You can buy a ton of options contracts comparatively to the capital required to go long on stocks. Playing the derivatives market is the way to go for day trading gains when you don’t really know shit.
This is helpful, but I wanted to confirm because I recall you work in big law, how does trading at your firm work? Can I go about my business and report later or do I have to clear trades with internal compliance folks before I invest?
Out of law and in cap markets, if I make a trade or buy a security typically compliance monitors it. If it conflicts with a deal or institution we work with, then it is blocked as sometimes I have no clue who the firm is doing deals with on other desks.
Unless you work in-house for a finance company (I used to be at Fidelity) then you should be fine. I don’t believe that outside counsel has to abide by those rules.
What’s the difference between buying a lottery ticket and buying a penny stock? In the first case, you help finance your local community swimming pool. In the second case, you help finance the stock promoters home pool.
Please eventually give us an update on all of your holdings and returns over whatever time period you guys pick. thanks
I’m gonna guess it’s gonna be somewhere along the lines of “buy high sell low.”
Will we get a competing blog from deFries?
Next week.
Tilray (TLRY) get on it.
That train has left the station. About 2 months ago.
Seconded